Position history for VANGUARD GROUP INC's holdings in BRIDGEBIO PHARMA INC
VANGUARD GROUP INC holds 16.9M shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.3B as of 2025-Q4. The position was increased (++0.2% shares). BBIO represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$1.3B
Current Shares
16.9M
Total Value Change
+$928.3M
Total Shares Change
+2.7M
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 16.9M |
+0.2% |
| $1.3B |
| 0.0% |
| $75.48 |
32 |
| 2025-Q3 | Increased | 16.8M | +2.1% | $874.3M | 0.0% | $51.96 | 32 |
| 2025-Q2 | Increased | 16.5M | +10.6% | $711.8M | 0.0% | $44.86 | 35 |
| 2025-Q1 | Decreased | 14.9M | -1.2% | $515.1M | 0.0% | $35.11 | 0 |
| 2024-Q4 | Increased | 15.1M | +6.2% | $413.7M | 0.0% | $27.32 | 33 |
| 2024-Q3 | New | 14.2M | - | $361.5M | 0.0% | $24.94 | 43 |